Medical Research
(H30)
IRS Verified
DX Registered
990 on File
BARBARA ANN KARMANOS CANCER INSTITUTE
Financial strength (30%)
85/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$25.4M
Total Revenue
$32.8M
Total Expenses
$211.9M
Net Assets
306
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.3%
Fundraising Efficiency
1685.7%
Operating Reserve
77.60x
Liability-to-Asset
15.5%
Revenue Diversification
43.4%
Executive Compensation
$3.8M
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.3% | 82.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
15.2% | 12.7% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
6.5% | 0.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1685.7% | 693.4% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
77.6 mo | 14.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
15.5% | 21.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
43.4% | 90.8% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
4.0% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
2.1% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-29.0% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $25.4M | $32.8M | $211.9M | 78.3% | 306 |
| 2023 | $24.4M | $32.1M | $227.9M | 84.1% | 319 |
| 2022 | $20.0M | $26.8M | $146.3M | 81.9% | 331 |
| 2021 | $20.6M | $25.7M | N/A | — | 309 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.